Medica Venture Partners logo

Medica Venture Partners

Asia, Tel Aviv, Israel, Herzliya

Description

Medica Venture Partners is a globally operating health care and life sciences venture capital fund investing in Israel, Europe and the

Investor Profile

Medica Venture Partners has made 13 investments, with 0 in the past 12 months and 15% as lead.

Stage Focus

  • Series Unknown (31%)
  • Series B (31%)
  • Series C (23%)
  • Series D (8%)
  • Debt Financing (8%)

Country Focus

  • United States (62%)
  • Israel (31%)
  • Germany (8%)

Industry Focus

  • Health Care
  • Medical Device
  • Medical
  • Biotechnology
  • Manufacturing
  • Health Diagnostics
  • Clinical Trials
  • Life Science
  • Information Technology
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Medica Venture Partners frequently co-invest with?

Gemini Israel Ventures
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 1
OrbiMed
North America, New York, United States, New York
Co-Investments: 3
FI
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 1
ABN AMRO Fund
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 2
Catalyst Fund LP
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 1
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 2
Pitango VC
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 4
DV
Europe, Brabant Wallon, Belgium, Waterloo
Co-Investments: 1
Oxford Bioscience Partners
North America, Massachusetts, United States, Boston
Co-Investments: 7
SCP Vitalife Partners
North America, Pennsylvania, United States, Wayne
Co-Investments: 2

Which angels does Medica Venture Partners often collaborate with?

DP
Asia, Tel Aviv, Israel, Tel Aviv
Shared Deals: 1
AO
Asia, Tel Aviv, Israel, Tel Aviv
Shared Deals: 1

What are some of recent deals done by Medica Venture Partners?

Regentis Biomaterials

Or Akiva, Hefa, Israel

Regentis Biomaterials develops and commercializes proprietary hydrogels for tissue regeneration.

BiotechnologyHealth CareMedical Device
Series DFeb 7, 2016
Amount Raised: $15,000,000
Regentis Biomaterials

Or Akiva, Hefa, Israel

Regentis Biomaterials develops and commercializes proprietary hydrogels for tissue regeneration.

BiotechnologyHealth CareMedical Device
Series CMay 14, 2012
Amount Raised: $10,000,000
SuperDimension

Minneapolis, Minnesota, United States

SuperDimension is a medical device company developing minimally invasive pulmonology devices for the treatment of distal lung disease.

Health CareMedicalMedical Device
Debt FinancingSep 7, 2010
Amount Raised: $15,000,000
SuperDimension

Minneapolis, Minnesota, United States

SuperDimension is a medical device company developing minimally invasive pulmonology devices for the treatment of distal lung disease.

Health CareMedicalMedical Device
Series UnknownSep 7, 2010
Amount Raised: $9,800,000
SuperDimension

Minneapolis, Minnesota, United States

SuperDimension is a medical device company developing minimally invasive pulmonology devices for the treatment of distal lung disease.

Health CareMedicalMedical Device
Series BJun 2, 2005
Amount Raised: $27,000,000
Remon Medical Technologies

Caesarea, Hefa, Israel

Remon Medical Technologies is a development-stage company focused on communication technology for medical device applications.

Health CareMedicalMedical Device
Series CJan 10, 2005
Amount Raised: $10,000,000
FlowMedica

Fremont, California, United States

FlowMedica is a medical device company which produces intravascular systems for implementing targeted renal therapy.

BiotechnologyHealth CareMedicalMedical Device
Series COct 11, 2004
Amount Raised: $5,600,000
Dynogen Pharmaceuticals

Boston, Massachusetts, United States

Dynogen is a privately held, neuroscience-based pharmaceutical company

Clinical TrialsLife ScienceMedical
Series BApr 20, 2004
Amount Raised: $50,000,000
SuperDimension

Minneapolis, Minnesota, United States

SuperDimension is a medical device company developing minimally invasive pulmonology devices for the treatment of distal lung disease.

Health CareMedicalMedical Device
Series UnknownJan 31, 2003
Amount Raised: $13,000,000
Percutaneous Valve Technologies (PVT)

Fort Lee, New Jersey, United States

The company develops medical devices for delivering heart valves to treat late-stage aortic stenosis.

Health CareInformation TechnologyMedical Device
Series BJan 1, 2003
Amount Raised: $14,000,000